CYTORI THERAPEUTICS, INC. (CYTX) has 114 open-market insider trades by 21 insiders since 2006. The most active filer is David Rickey, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Corp Olympus | 10% | — | 2 | $17.0M | 2008-08-07 |
| Christopher J. Calhoun | CEO | — | 16 | $1.4M | 2014-01-10 |
| Kian Thiam Lim | 10% | — | 1 | $822K | 2015-04-06 |
| David Rickey | Dir | — | 30 | $677K | 2016-06-15 |
| Ag PostFinance | 10% Owner | — | 3 | $627K | 2018-02-14 |
| Marc H. Hedrick | Pres | — | 14 | $276K | 2016-06-15 |
| Paul W. Hawran | Dir | — | 8 | $251K | 2015-05-08 |
| Mark E. Saad | CFO | — | 10 | $226K | 2013-01-31 |
| Lloyd H. Dean | Dir | — | 4 | $121K | 2014-05-19 |
| Ronald D. Henriksen | Dir | — | 5 | $113K | 2012-01-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ag PostFinance | 10% Owner | Sell | $322K | 2018-02-14 |
| Ag PostFinance | 10% Owner | Sell | $146K | 2018-02-12 |
| Ag PostFinance | 10% Owner | Sell | $158K | 2018-02-08 |
| Sa Swissquote Bank | 10% | Sell | $48K | 2018-01-09 |
| John David Harris | VP and GM Cell Therapy | Buy | $5K | 2016-08-10 |
| David Rickey | Director | Buy | $11K | 2016-06-14 |
Companies that share insiders with CYTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Gail K. Naughton | Director | Buy | $2K | 2016-06-14 |
| John David Harris | VP and GM Cell Therapy | Buy | $5K | 2016-05-13 |
| David Rickey | Director | Buy | $29K | 2016-03-09 |
| Tommy G. Thompson | Director | Buy | $9K | 2015-09-03 |
| Jeremy B. Hayden | General Counsel & VP of BD | Buy | $3K | 2015-09-02 |
| David Rickey | Director | Buy | $17K | 2015-08-28 |
| Marc H. Hedrick | President | Buy | $3K | 2015-08-27 |
| David Rickey | Director | Buy | $23K | 2015-08-26 |
| Marc H. Hedrick | President | Buy | $2K | 2015-08-21 |